Ongoing transmission of Bundibugyo virus in the Democratic Republic of the Congo since the May 2026 outbreak declaration has established clear frontrunner status for reported cases there, with over 3,900 confirmed infections and the WHO's public health emergency designation amplifying momentum. Uganda recorded 20 cases before declaring the outbreak over in late July, while imported instances treated in France and Germany highlight how medical evacuations can expand the field. Traders monitor cross-border movement, healthcare worker infections, and any new precursor signals like cluster reports in neighboring regions, as historical patterns show limited but unpredictable spread beyond Central Africa. The campaign against further cases depends on containment efforts through year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$32,095 Vol.
31 dez 2026
South Sudan
61%
Rwanda
30%
Burundi
27%
United States
22%
Canada
26%
Kenya
47%
India
22%
Republic of the Congo
22%
Nigeria
22%
Ethiopia
50%
Somalia
30%
China
22%
$32,095 Vol.
South Sudan
$1,769 Vol.
61%
Rwanda
$2,128 Vol.
30%
Burundi
$200 Vol.
27%
United States
$9,586 Vol.
22%
Canada
$1,086 Vol.
26%
Kenya
$193 Vol.
47%
India
$732 Vol.
22%
Republic of the Congo
$11,674 Vol.
22%
Nigeria
$25 Vol.
22%
Ethiopia
$65 Vol.
50%
Somalia
$71 Vol.
30%
China
$2,610 Vol.
22%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing transmission of Bundibugyo virus in the Democratic Republic of the Congo since the May 2026 outbreak declaration has established clear frontrunner status for reported cases there, with over 3,900 confirmed infections and the WHO's public health emergency designation amplifying momentum. Uganda recorded 20 cases before declaring the outbreak over in late July, while imported instances treated in France and Germany highlight how medical evacuations can expand the field. Traders monitor cross-border movement, healthcare worker infections, and any new precursor signals like cluster reports in neighboring regions, as historical patterns show limited but unpredictable spread beyond Central Africa. The campaign against further cases depends on containment efforts through year-end.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Mercado Aberto: May 22, 2026, 12:35 PM ET
Volume
$32,095Data de Término
31 dez 2026Mercado Aberto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing transmission of Bundibugyo virus in the Democratic Republic of the Congo since the May 2026 outbreak declaration has established clear frontrunner status for reported cases there, with over 3,900 confirmed infections and the WHO's public health emergency designation amplifying momentum. Uganda recorded 20 cases before declaring the outbreak over in late July, while imported instances treated in France and Germany highlight how medical evacuations can expand the field. Traders monitor cross-border movement, healthcare worker infections, and any new precursor signals like cluster reports in neighboring regions, as historical patterns show limited but unpredictable spread beyond Central Africa. The campaign against further cases depends on containment efforts through year-end.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$32,095Data de Término
31 dez 2026Mercado Aberto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...Ongoing transmission of Bundibugyo virus in the Democratic Republic of the Congo since the May 2026 outbreak declaration has established clear frontrunner status for reported cases there, with over 3,900 confirmed infections and the WHO's public health emergency designation amplifying momentum. Uganda recorded 20 cases before declaring the outbreak over in late July, while imported instances treated in France and Germany highlight how medical evacuations can expand the field. Traders monitor cross-border movement, healthcare worker infections, and any new precursor signals like cluster reports in neighboring regions, as historical patterns show limited but unpredictable spread beyond Central Africa. The campaign against further cases depends on containment efforts through year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions